Tuberculosis vaccines: Beyond bacilli Calmette-Guérin

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin

Tuberculosis (TB) disease caused by Mycobacterium tuberculosis (M. tb) remains one of the leading infectious causes of death and disease throughout the world. The only licensed vaccine, Mycobacterium bovis bacille Calmette-Gue ́rin (BCG) confers highly variable protection against pulmonary disease....

Fuld beskrivelse

Bibliografiske detaljer
Hovedforfatter:	McShane, H
Format:	Journal article
Sprog:	English
Udgivet:	2011

Lignende værker

Tuberculosis vaccines: beyond bacille Calmette–Guérin
af: McShane, H
Udgivet: (2011)

Bacille Calmette-Guérin Vaccination and Tuberculosis
af: Nick R Anthonisen
Udgivet: (2005-01-01)

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats
af: Yajuan Wang, et al.
Udgivet: (2011-09-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
af: Renata Monteiro-Maia, et al.
Udgivet: (2014-09-01)

Timeliness of Bacilli Calmette-Guérin vaccination among infants in a tertiary health facility in sub-Saharan Africa
af: Ekop EE, et al.
Udgivet: (2021-07-01)

Effectiveness of bacillus Calmette–Guerin vaccination history on pulmonary tuberculosis symptoms
af: Safar Farajnia, et al.
Udgivet: (2019-12-01)

The Use of Bacille Calmette-Guérin vaccination in Children
af: David P Speert
Udgivet: (1995-01-01)

Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination
af: Sayori Kobayashi, et al.
Udgivet: (2021-08-01)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
af: Natalie E. Nieuwenhuizen, et al.
Udgivet: (2018-02-01)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
af: Minassian, A, et al.
Udgivet: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
af: Minassian, A, et al.
Udgivet: (2012)

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
af: Magdalena Jurczak, et al.
Udgivet: (2025-02-01)

The management and outcome of Bacillus Calmette–Guérin vaccine overdose
af: Sung-Hsi Wei, et al.
Udgivet: (2018-04-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
af: Rolandas Selvestravičius, et al.
Udgivet: (2016-09-01)

The Lack of Association Between Bacille Calmette-Guerin Vaccination and Clustering of Aboriginals with Tuberculosis in Western Canada
af: Victoria J Cook, et al.
Udgivet: (2005-01-01)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
af: Maria Carolina Sisco, et al.
Udgivet: (2020-05-01)

Bacillus Calmette–Guérin and Bladder Cancer
af: Azad H.A. Razack
Udgivet: (2007-10-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
af: Lwandile Bukula, et al.
Udgivet: (2025-03-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
af: B N Shiva Prasad
Udgivet: (2022-01-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
af: Sarah Hamdy Soliman, et al.
Udgivet: (2023-01-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
af: Patricia Méndez-Samperio
Udgivet: (2019-06-01)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
af: Yanin Chavarri-Guerra, et al.
Udgivet: (2019-12-01)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
af: Badria Al Waili, et al.
Udgivet: (2021-02-01)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
af: Fletcher, H, et al.
Udgivet: (2016)

A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette–Guérin-vaccinated Individuals
af: Delfina Peña, et al.
Udgivet: (2015-08-01)

Bacillus Calmette–Guérin Immunotherapy for Cancer
af: Fabíola Cardillo, et al.
Udgivet: (2021-05-01)

Evaluation of the specificity of an intradermal test with recombinant tuberculosis allergen in Bacillus Calmette–Guérin-vaccinated healthy volunteers
af: Irina A. Vasilyeva, et al.
Udgivet: (2023-03-01)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
af: Minhinnick, A, et al.
Udgivet: (2015)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
af: Paola Villanueva, et al.
Udgivet: (2022-01-01)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
af: Sara Feola, et al.
Udgivet: (2021-07-01)

Research progress in the off-target effects of Bacille Calmette–Guérin vaccine
af: Yanfei Wu, et al.
Udgivet: (2024-09-01)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
af: Junli Li, et al.
Udgivet: (2021-01-01)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
af: Junli Li, et al.
Udgivet: (2022-07-01)

Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
af: Mitchell V. Palmer, et al.
Udgivet: (2018-10-01)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
af: Paola Villanueva, et al.
Udgivet: (2022-01-01)

Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guérin vaccination
af: Maryam Shoaran, et al.
Udgivet: (2013-11-01)

The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
af: Jakub Krzysztof Gałązka
Udgivet: (2022-10-01)

Bacille Calmette-Guérin Vaccination in Saudi Arabia: Benefits versus Risks
af: Suliman Al Jumaah, et al.
Udgivet: (2012-01-01)

Lymphadenitis and lichen scofulosorum following bacille calmette-guérin vaccination in an infant
af: Taru Garg, et al.
Udgivet: (2021-01-01)

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination
af: Esther J.M. Taks, et al.
Udgivet: (2023-11-01)